Want to see MRK full AI Analyst Report?
Merck & Company (MRK) Income Statement
Merck & Company Income Statement
Last quarter (Q2 2026), Merck & Company's total revenue was $16.61B, an increase of 5.11% from the same quarter last year. In Q2, Merck & Company's net income was $-1.33B. See Merck & Company’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 |
|---|---|---|---|---|---|
| $ 64.93B | $ 64.17B | $ 60.12B | $ 59.28B | $ 48.70B | |
| $ 46.73B | $ 48.98B | $ 43.99B | $ 41.87B | $ 35.08B | |
| $ 23.25B | $ 28.75B | $ 41.03B | $ 23.59B | $ 21.88B | |
| Depreciation and Amortization | $ 5.84B | $ 4.50B | $ 3.87B | $ 3.91B | $ 3.21B |
| $ 28.26B | $ 25.71B | $ 6.91B | $ 21.32B | $ 17.90B | |
| $ 23.49B | $ 20.22B | $ 2.95B | $ 18.28B | $ 13.20B | |
| $ -2.42B | $ -285.00M | $ -1.06B | $ -1.84B | $ 680.00M | |
| $ 21.07B | $ 19.94B | $ 1.89B | $ 16.44B | $ 13.88B | |
| $ 18.25B | $ 17.12B | $ 365.00M | $ 14.52B | $ 13.05B | |
| Per Share Metrics | |||||
| Basic EPS | $ 7.30 | $ 6.74 | $ 0.14 | $ 5.73 | $ 5.16 |
| Diluted EPS | $ 7.28 | $ 6.74 | $ 0.14 | $ 5.71 | $ 5.14 |
| Weighted Average Shares Outstanding | 2.50B | 2.53B | 2.55B | 2.53B | 2.53B |
| Weighted Average Shares Outstanding (Diluted) | 2.51B | 2.54B | 2.55B | 2.54B | 2.54B |
Currency in USD
